Optimize Quality, Costs & Carbon-Efficiency Through Robust Applications of Continuous Processing for All Modalities

1 WEEK TO GO, LAST CHANCE TO REGISTER

Day
Hour
Minute
Second
FULL EVENT GUIDE
REGISTER
PARTNER

Welcome to the 9th Commercializing Continuous Processing Summit 2025

Drive Pipeline Sustainability With the Targeted Application of Continuous Processing in Pharma 

The pivotal shift in biopharma priorities is steering towards enhancing sustainability measures for drug development. Continuous processing keeps the industry grounded in reaching propelled ESG goals whilst keeping capital spend to a minimum. With the previous release of the ICH Q13 broadening the scope of support for continuous manufacturing as a greener alternative, continuous processing is unstoppable in its efforts to drive formulation efficiency and supply chain resilience across all modalities. 

In collaboration with AstraZeneca, Pfizer, Sanofi, and Ultragenyx, the 9th Commercializing Continuous Processing Summit returns to you with a new strategic focus and novel case-studies spanning small molecule, biologics and emerging modalities to secure internal support for your continuous shift, and edge towards first-class, quality therapeutics for patients. 

What will you learn at the 9th CCP Summit?

55762 svg - 9th CCP Summit

Uncover process modeling advancements to aid small molecule tech transfer and minimize troubleshooting time

55762 svg - 9th CCP Summit

Explore revolutionary ADC and peptide production case-studies to transform traditional biologics development

55762 svg - 9th CCP Summit

Assess modality agnostic learnings across PAT and CDMO management to promote end-to-end processing success

55762 svg - 9th CCP Summit

Identify digital twin applications for new levels of efficiency during continuous processing

55762 svg - 9th CCP Summit

Learn from pharma-led continuous processing projects across small molecule, biologics, cell and gene therapy to optimize yields, and enhance green chemistry

Whether you are specialized in small molecule, biologics, or cell and gene therapy, the 9th CCP Summit caters to all. Join 60+ of your peers across process development, CMC, and analytical development to revolutionize your development pipeline. 

World-Class Speaker Faculty Includes:

Dan Griffin - 9th CCP Summit

Daniel Griffin

Associate Director - Engineering

Amgen Inc.

Florent peral - 9th CCP Summit

Florent Peral

GMP Investigator

Sanofi

Juan Colberg - 9th CCP Summit

Juan Colberg

Senior Director Technology & Innovation, Global Green Chemistry Leader

Pfizer

julie wei headshot - 9th CCP Summit

Julie Wei

Associate Director

Ultragenyx Pharmaceutical

Paria Coliaie

Senior Scientist I

Abbvie

Terrence Dobrowsky - 9th CCP Summit

Terrence Dobrowsky

Head of Biotherapeutics Technology Development & Implementation

Takeda

VIEW SPEAKERS

Previously Attending Companies Included:

previously attending companies - 9th CCP Summit

What Past CCP Attendees Had to Say:

 

“Quality and topic of the talks are great. The 2-day event covers all areas in commercializing CM processes.”

Principal Scientist, Amgen, Previous Attendee


“The volume of information available on Continuous Manufacturing was really strong. It had a wide range of attendees from different parts of the pharma community. It also was a chance to find out what's going on in the industry.”

Senior Team Lead - External Manufacturing, Bayer, Previous Attendee 

 

“The themes from each speaker tied in nicely across both days and I learned useful information from the small molecule side that I can apply to biologics.”

Head of Cell Culture & Cell Line Development, Biogen, Previous Attendee 

FULL EVENT GUIDE
REGISTER
PARTNER

Other Events in the Series